Saturday, October 10, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

SodaPeak Gummies Introduces Soda Peak, a Multi-Ingredient Dietary Supplement Formulated for Men’s Energy and Vitality

October 10, 2026
in GlobeNewswire, Web3
Reading Time: 22 mins read
5
SHARES
248
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

SodaPeak’s Soda Peak Gummies fo mulatio i cludes Mui a Puama Ext act, Maca Ext act, Catuaba Ext act, G ee Tea Ext act, Caffei e, a d Ashwaga dha.

Wilmi gto , DE, Oct. 10, 2026 (GLOBE NEWSWIRE) — SodaPeak has i t oduced Soda Peak Gummies, a multi-i g edie t dieta y suppleme t fo mulated with six listed i g edie ts: Mui a Puama Ext act, Maca Ext act, Catuaba Ext act, G ee Tea Ext act, Caffei e, a d Ashwaga dha. The fo mulatio combi es bota ical i g edie ts with caffei e withi the dieta y suppleme t catego y associated with me ‘s e e gy a d vitality.

Official Website: https://sodapeak.shop/

The i t oductio of Soda Peak p ovides a oppo tu ity to exami e the p oduct’s stated fo mulatio a d the b oade scie tific co text su ou di g its i g edie ts. SodaPeak’s listed i g edie ts have diffe e t histo ies of t aditio al use, a d the amou t of esea ch available va ies co side ably betwee them. U de sta di g these diffe e ces is impo ta t whe evaluati g i fo matio about bota ical suppleme ts.

I te est i me ‘s well ess p oducts e compasses seve al a eas, i cludi g eve yday e e gy, physical activity, ge e al well-bei g, a d bota ical i g edie ts. Howeve , the i clusio of a i g edie t i a comme cial suppleme t does ot establish that the fi ished p oduct p oduces a pa ticula health outcome. Such co clusio s equi e app op iate evide ce elati g to the actual fo mulatio .

U de sta di g the P oduct Fo mulatio

Soda Peak co tai s six listed i g edie ts that se ve as the basis fo u de sta di g its fo mulatio . These i clude th ee bota icals commo ly associated with t aditio al he bal p actices, g ee tea ext act, caffei e, a d ashwaga dha.

SodaPeak combi es i g edie ts that diffe i thei bota ical o igi s, chemical compositio s, a d esea ch histo ies. Bota ical ext acts may va y acco di g to pla t species, the pa t of the pla t used, g owi g co ditio s, p ocessi g methods, a d ext actio tech iques.

These diffe e ces ca i flue ce the cha acte istics of the fi al i g edie t. Fo example, a co ce t ated ext act may ot have the same compositio as a powde ed pla t mate ial, eve whe both o igi ate f om the same bota ical sou ce.

A complete assessme t of Soda Peak would equi e i fo matio about the qua tity of each i g edie t, the p epa atio of the ext acts, a d a y applicable sta da dizatio specificatio s. The listed i g edie ts ide tify the b oad fo mulatio but do ot i depe de tly establish the p oduct’s effective ess o safety fo eve y co sume .

Mui a Puama Ext act a d T aditio al Bota ical P actices

Mui a puama is associated with t aditio al he bal p actices i pa ts of South Ame ica. It has histo ically bee discussed i co ectio with me ‘s well ess a d sexual health, co t ibuti g to its p ese ce i some co tempo a y bota ical fo mulatio s.

The ame is commo ly associated with pla ts i the ge us Ptychopetalum. Accu ate bota ical ide tificatio is impo ta t because comme cial i g edie t desc iptio s a d the species used i diffe e t p epa atio s may va y.

Scie tific esea ch i to mui a puama emai s limited compa ed with esea ch o mo e exte sively studied i g edie ts. T aditio al use a d p elimi a y fi di gs ca p ovide histo ical o scie tific co text, but they do ot i depe de tly demo st ate that a pa ticula suppleme t p oduces a defi ed health be efit.

Resea ch must also be i te p eted acco di g to the p epa atio studied, the amou t admi iste ed, the du atio of use, a d the cha acte istics of the pa ticipa ts. Without those details, it is difficult to dete mi e whethe fi di gs f om a study apply to a comme cial ext act.

Mui a Puama Ext act is o e of the i g edie ts listed i SodaPeak’s fo mulatio . Fu the i fo matio about its bota ical ide tity, co ce t atio , a d ext actio p ocess would help establish a clea e basis fo compa i g the i g edie t with published esea ch.

Maca Ext act a d Scie tific I vestigatio

Maca, scie tifically k ow as Lepidium meye ii, is a pla t ative to the A dea egio of South Ame ica. Its oot has a histo y of use as a food a d t aditio al bota ical p epa atio . Co tempo a y p oducts co tai i g maca i clude powde s, capsules, beve ages, a d dieta y suppleme ts.

Resea ch has exami ed maca i elatio to seve al a eas of huma health, i cludi g aspects of sexual well-bei g, mood, a d subjective e e gy. The evide ce va ies by outcome, p epa atio , a d study quality, a d fi di gs f om o e study should ot automatically be ge e alized to eve y maca-co tai i g p oduct.

Maca powde a d co ce t ated ext acts may diffe i compositio . P ocessi g tech iques a d se vi g sizes ca also i flue ce compa iso s betwee comme cially available i g edie ts a d mate ials exami ed i esea ch.

Small study populatio s, sho t obse vatio pe iods, a d diffe e ces i esea ch methods ca limit the st e gth of co clusio s. The p ese ce of maca i a fo mulatio is the efo e ot sufficie t evide ce of a specific outcome.

Maca Ext act is i cluded i Soda Peak. To u de sta d its co t ibutio to the complete p oduct, additio al i fo matio about its qua tity a d p epa atio would be ecessa y. Resea ch i volvi g maca alo e would also eed to be disti guished f om esea ch co ducted specifically o the fi ished fo mulatio .

Catuaba Ext act a d Bota ical Ide tificatio

Catuaba is a ame associated with ce tai pla ts used i t aditio al B azilia he bal p actices. The te m does ot always efe to a si gle bota ical species, maki g accu ate ide tificatio eleva t to i g edie t evaluatio .

Catuaba has t aditio ally bee discussed i co ectio with vitality a d sexual well ess. These associatio s p ovide co text fo its appea a ce i co tempo a y bota ical suppleme ts, but t aditio al use should ot be co fused with established cli ical effective ess.

Scie tific evide ce co ce i g catuaba emai s limited. Diffe e ces i pla t species, pla t pa ts, a d ext actio methods ca make compa iso s betwee comme cial i g edie ts a d published studies difficult.

A tho ough assessme t would equi e the p ecise bota ical ide tity, the pla t mate ial used, a d details about ext actio a d p ocessi g. Huma esea ch would also eed to exami e clea ly defi ed outcomes usi g app op iate methods.

Because SodaPeak i cludes catuaba alo gside seve al othe i g edie ts, dete mi i g the co t ibutio of this bota ical would equi e mo e tha evide ce about the isolated i g edie t. Studies of the complete fo mulatio would p ovide mo e eleva t i fo matio about the combi ed p oduct.

G ee Tea Ext act a d Its Compositio

G ee tea is p oduced f om the leaves of Camellia si e sis. Depe di g o p epa atio a d p ocessi g, it co tai s va yi g co ce t atio s of polyphe ols k ow as catechi s. O e widely studied catechi is epigallocatechi gallate, commo ly abb eviated as EGCG.

G ee tea is co sumed as a beve age a d is also used i co ce t ated dieta y suppleme t ext acts. The chemical compositio of co ce t ated ext acts may diffe f om that of b ewed tea, depe di g o the ma ufactu i g p ocess a d co ce t atio .

Resea ch has exami ed g ee tea a d its co stitue ts i seve al a eas of huma health. Howeve , fi di gs i volvi g o e p epa atio ca ot automatically be applied to all g ee tea p oducts.

Safety is a impo ta t co side atio whe evaluati g co ce t ated ext acts. Ce tai high-dose g ee tea ext act p epa atio s have bee associated with live i ju y. Risk may depe d o the dose, ext act compositio , a d othe facto s, i cludi g whethe the ext act is co sumed with food.

The qua tity of g ee tea ext act a d its catechi co te t a e the efo e eleva t details fo evaluati g Soda Peak. The listed i g edie t ame alo e does ot establish the co ce t atio o the amou t of caffei e that may be co t ibuted by the ext act.

Caffei e a d Eve yday E e gy

Caffei e is a stimula t fou d atu ally i coffee bea s, tea leaves, a d seve al othe pla t sou ces. It is also used i foods, beve ages, a d dieta y suppleme ts.

Caffei e has bee exte sively studied i huma s. Depe di g o the amou t co sumed a d i dividual se sitivity, it ca tempo a ily i c ease ale t ess a d educe the pe ceptio of fatigue. Its effects va y acco di g to habitual i take, timi g, sleep patte s, a d i dividual diffe e ces i caffei e metabolism.

Caffei e ca also cause u wa ted effects, i cludi g e vous ess, estless ess, digestive discomfo t, i c eased hea t ate, a d difficulty sleepi g. People diffe i thei se sitivity, a d some may expe ie ce these effects at elatively low amou ts.

Total daily i take matte s because caffei e ca come f om coffee, tea, e e gy d i ks, chocolate, medicatio s, a d othe suppleme ts. Assessi g a caffei e-co tai i g p oduct equi es co side atio of these combi ed sou ces.

G ee tea ext act may also co tai caffei e, depe di g o the p epa atio . Fo that easo , a complete assessme t of SodaPeak’s fo mulatio would equi e i fo matio about the total caffei e co te t pe se vi g, i cludi g a y caffei e co t ibuted by the g ee tea ext act.

Caffei e is listed sepa ately amo g the i g edie ts i Soda Peak. Without ve ified qua tities, howeve , the p oduct’s total caffei e co te t a d its effects o i dividual co sume s ca ot be dete mi ed f om the i g edie t list alo e.

Ashwaga dha a d Co tempo a y Resea ch

Ashwaga dha, scie tifically k ow as Witha ia som ife a, is a pla t used i t aditio al Ayu vedic p actices. Its oots a d, i some p epa atio s, othe pla t pa ts a e used i co tempo a y bota ical suppleme ts.

Resea che s have exami ed ashwaga dha i elatio to pe ceived st ess, sleep, a d ce tai measu es of physical pe fo ma ce. Some studies have epo ted fi di gs of i te est, but the st e gth of the evide ce va ies acco di g to the outcome, p epa atio , dose, a d study desig .

Ashwaga dha p oducts a e ot ecessa ily i te cha geable. They may diffe i the pla t pa ts used, ext actio methods, a d co ce t atio s of atu ally occu i g compou ds called witha olides.

Fi di gs i volvi g o e sta da dized ext act should ot automatically be applied to eve y p oduct co tai i g ashwaga dha. Likewise, esea ch i volvi g a isolated i g edie t ca ot establish the effective ess of a multi-i g edie t fo mulatio without app op iate p oduct-specific evide ce.

Safety also equi es co side atio . Ashwaga dha may cause digestive symptoms o d owsi ess a d has bee associated with a e cases of live i ju y. It may affect thy oid fu ctio a d i te act with ce tai medicatio s.

People who a e p eg a t o b eastfeedi g, have existi g health co ditio s, o take p esc iptio medici es should co sult a qualified healthca e p ofessio al befo e usi g suppleme ts co tai i g ashwaga dha.

Ashwaga dha is o e of the six listed i g edie ts i Soda Peak. I fo matio about the ext act type, amou t, a d sta da dizatio would be ecessa y to compa e the i g edie t mea i gfully with p epa atio s exami ed i scie tific studies.

Evaluati g Multi-I g edie t Dieta y Suppleme ts

Combi i g seve al i g edie ts i a si gle fo mulatio is a commo app oach i the dieta y suppleme t i dust y. This app oach b i gs diffe e t bota ical mate ials a d othe compo e ts togethe i o e p oduct, but it also c eates questio s about compositio , safety, a d scie tific evide ce.

Resea ch o a i dividual i g edie t does ot establish that a combi atio will p oduce the same effects. Evaluati g the fi ished p oduct ge e ally equi es esea ch o the actual fo mulatio , with clea ly docume ted i g edie ts a d se vi g sizes.

Releva t study co side atio s i clude pa ticipa t cha acte istics, du atio , compa iso g oups, measu ed outcomes, a d publicatio quality. Both positive a d i co clusive fi di gs should be i te p eted ca efully.

I g edie t quality is a othe co side atio . Bota ical mate ials may va y i compositio a d ca be vul e able to co tami atio o substitutio without suitable sou ci g a d quality co t ols.

Ma ufactu i g p ocedu es, i g edie t ide tity testi g, a d app op iate co tami a t testi g ca p ovide useful i fo matio about SodaPeak quality. Whe e i depe de t testi g is epo ted, the testi g scope a d the o ga izatio co ducti g the assessme t a e eleva t to i te p eti g the esults.

Fo SodaPeak, a mo e comp ehe sive evaluatio would equi e i fo matio about i g edie t qua tities, bota ical sou ci g, ma ufactu i g p actices, a d a y esea ch co ducted o the ma keted fo mulatio .

Co sume Safety a d Respo sible Use

Dieta y suppleme ts should be co side ed i the co text of a i dividual’s ove all health, diet, lifestyle, a d medical ci cumsta ces. SodaPeak i te ded catego y does ot establish that it is app op iate fo eve y adult.

Co sume s co side i g Soda Peak Gummies should eview the complete p oduct label, i cludi g se vi g i st uctio s, i g edie t qua tities, a d wa i gs. They should also co side caffei e obtai ed f om othe sou ces th oughout the day.

Pote tial i te actio s a e pa ticula ly eleva t fo people taki g medicatio o ma agi g existi g health co ditio s. A fo mulatio co tai i g seve al active i g edie ts may p ese t additio al assessme t challe ges because the combi ed safety p ofile may be less well u de stood tha that of a i dividual compo e t.

Pe siste t fatigue o cha ges i sexual fu ctio ca sometimes be associated with u de lyi g health co ditio s, sleep difficulties, st ess, ut itio al issues, o medicatio effects. Such co ce s may wa a t assessme t by a qualified healthca e p ofessio al athe tha elia ce o a dieta y suppleme t alo e.

Co sume s should disti guish betwee the p ese ce of a i g edie t a d evide ce that the complete p oduct p oduces a specific esult. T aditio al use, p elimi a y esea ch, a d i g edie t desc iptio s a e ot gua a tees of a pa ticula outcome.

Regulato y a d Scie tific Co side atio s

Dieta y suppleme t equi eme ts va y by ju isdictio . Regulatio s gove i g ma ufactu i g, labeli g, safety, a d p oduct claims diffe ac oss ma kets.

I the U ited States, dieta y suppleme ts a e egulated u de a f amewo k disti ct f om the app oval p ocess fo p esc iptio medici es. The U.S. Food a d D ug Admi ist atio does ot ge e ally app ove dieta y suppleme ts fo safety a d effective ess befo e they a e ma keted. Ma ufactu e s a d dist ibuto s emai espo sible fo complyi g with applicable safety, ma ufactu i g, a d labeli g equi eme ts.

Claims must be app op iately substa tiated a d must ot mislead co sume s. SodaPeak desc iptio s should ot imply that a suppleme t diag oses, t eats, cu es, o p eve ts a disease u less the claim is pe mitted u de the applicable egulato y f amewo k.

Scie tific commu icatio also equi es a clea disti ctio betwee i g edie t esea ch a d evide ce about the fi ished p oduct. Resea ch i volvi g elated bota ical p epa atio s should be desc ibed accu ately, i cludi g limitatio s that affect the i te p etatio of fi di gs.

A comp ehe sive assessme t of SodaPeak Gummies would co side i g edie t ide tity, qua tities, ext act specificatio s, safety i fo matio , ma ufactu i g docume tatio , a d a y cli ical studies co ducted o the complete fo mulatio .

About Soda Peak 

SodaPeak has i t oduced Soda Peak Gummies, a multi-i g edie t dieta y suppleme t co tai i g Mui a Puama Ext act, Maca Ext act, Catuaba Ext act, G ee Tea Ext act, Caffei e, a d Ashwaga dha.

The i g edie ts have diffe e t histo ies of use a d va yi g levels of scie tific i vestigatio . Caffei e has bee exte sively studied fo specific physiological effects, while esea ch co ce i g seve al of the listed bota icals emai s limited o depe de t o the p epa atio exami ed.

A complete u de sta di g of Soda Peak Gummies would equi e additio al i fo matio about i g edie t qua tities, bota ical sou ci g, ext act sta da dizatio , ma ufactu i g quality, a d p oduct-specific esea ch. These details a e impo ta t whe disti guishi g a p oduct’s stated compositio f om evide ce of its effective ess.

T a spa e t labeli g a d app op iately qualified scie tific i fo matio emai impo ta t to espo sible commu icatio about dieta y suppleme ts. Sepa ati g t aditio al use f om cli ical evide ce, a d i g edie t esea ch f om fi di gs about fi ished p oducts, helps eade s u de sta d the available i fo matio about SodaPeak a d the b oade me ‘s well ess suppleme t catego y.

CONTACT: Email Suppo t: co tact@sodapeak.shop
Numbe Suppo t: +1 (507) 448-8190

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

Immutable Holdings and Jorge Masvidal’s Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV

Related Posts

LigoLab Introduces AI-Assisted Voice Interface for Anatomic Pathology Workflows

GLENDALE, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- LigoLab, a p ovide of labo ato y i fo matio system (LIS) a d labo ato y eve ue cycle ma ageme t solutio s, has i t oduced LigoLab Voice, a AI-assisted, ha ds-f ee i te face i teg...

Read moreDetails

Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice

NANCHANG, Chi a, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Rua yu Edai Tech ology I c. (NASDAQ: RYET) (the "Compa y") today a ou ced that it eceived a w itte otice dated Octobe 7, 2026 f om Nasdaq stati g that the closi g bid p ice of its...

Read moreDetails

Vadzo Imaging Validates Merlin-290CRS: 2MP Sony IMX290 Low-Light USB Camera with High-Performance ISP for Smart Surveillance

The Me li -290CRS is a 2MP colo olli g shutte USB came a built o the So y IMX290 se so a d tu ed a ou d a high-pe fo ma ce image sig al p ocesso specifically fo secu ity a d su veilla ce wo kloads....

Read moreDetails

Wellows Publishes AI Citation Study Based on 9,471 Prompts

Wellows has published a ew esea ch study exami i g AI citatio patte s ac oss 9,471 p ompts. The study a alyzed 382,176 AI a swe s ac oss ChatGPT, Gemi i, Pe plexity, Google AI Ove views, a d Google AI Mode. Sites cited ofte o othe...

Read moreDetails

Axe Compute (NASDAQ: AGPU) to Ring the Nasdaq Stock Market Opening Bell on October 12, 2026

Ce emo y ma ks a milesto e fo the AI i f ast uctu e compa y followi g sig ifica t comme cial g owth a d co ti ued expa sio of its dedicated GPU compute capacityNEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Axe Compute I...

Read moreDetails

Cavitation Technologies, Inc. Announces Definitive Agreements with BrightFlixx Finance (Luxembourg) S.A. for Aggregate Proposed Cash Consideration of $42 Million

CHATSWORTH, Calif., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Cavitatio Tech ologies, I c. (OTCQB: CVAT) ("CVAT" o the "Compa y"), a leadi g p ovide of sustai able a otech ology solutio s, today a ou ced that it has e te ed i to defi itive pu chase ag...

Read moreDetails

QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Sha es back above $1.00 fo 6 co secutive t adi g days Ness Zio a, Is ael, Oct. 09, 2026 (GLOBE NEWSWIRE) -- QTREX Qua tum Ltd. (Nasdaq: QTEX) (“QTREX” o the “Compa y”), a compa y focused o adva ci g Additively Ma ufactu ed Elect o ics...

Read moreDetails

GlycoDefender Capsules Introduces Glyco Defender Multi-Ingredient Dietary Supplement

Glyco Defe de a ou ceme t outli es a bota ical fo mulatio co tai i g maca oot, Af ica ma go, g ape seed, gua a a seed, eleuthe o oot, a d g ee tea leaf ext act.Ogde , UT, Oct. 09, 2026 (GLOBE NEWSWIRE) --...

Read moreDetails

Thermo Ignite Drops Introduces ThermoIgnite Liquid Multi-Ingredient Dietary Supplement Formulation

The mo Ig ite D ops a ou ceme t outli es a fo mulatio co tai i g ch omium picoli ate, L-ca iti e HCl, g ee tea ext act, Gym ema sylvest e ext act, a d Af ica ma go seed ext act.Au o a, CO,...

Read moreDetails

UPDATED: TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq

Polymath, c eato of the Polymesh Laye -1 blockchai , becomes pa t of Nasdaq-listed T uGolf (NASDAQ: TRUG). Natalie Hi sch is amed CFO a d COO, a d a $2.95 millio wa a t exe cise st e gthe s the compa y's cash positio . Salt Lake...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Understanding Soulbound Tokens SBT Their Definition and Significance

    81 shares
    Share 32 Tweet 20
  • Top Cross-Chain DeFi Solutions to Watch by 2025

    186 shares
    Share 74 Tweet 47
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    185 shares
    Share 74 Tweet 46
  • Top Layer 1 Crypto Projects to Watch in 2025

    37 shares
    Share 15 Tweet 9
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    109 shares
    Share 44 Tweet 27
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • SodaPeak Gummies Introduces Soda Peak, a Multi-Ingredient Dietary Supplement Formulated for Men’s Energy and Vitality
  • Immutable Holdings and Jorge Masvidal’s Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
  • LigoLab Introduces AI-Assisted Voice Interface for Anatomic Pathology Workflows
  • Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
  • Americas Cardroom Outlines Pro Streaming Schedule for $6.5M Dual Venom PKOs

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.